Protein kinase 2 (CK2): a potential regulator of immune cell development and function in cancer

Protein kinase CK2, formally known as casein kinase II, is ubiquitously expressed and highly conserved serine/threonine or tyrosine kinase enzyme that regulates diverse signaling pathways responsible for cellular processes (i.e., cell proliferation and apoptosis) via interactions with over 500 known...

Full description

Bibliographic Details
Main Authors: Kazim Husain, Tanika T. Williamson, Nadine Nelson, Tomar Ghansah
Format: Article
Language:English
Published: Taylor & Francis Group 2021-07-01
Series:Immunological Medicine
Subjects:
Online Access:http://dx.doi.org/10.1080/25785826.2020.1843267
_version_ 1818407310637137920
author Kazim Husain
Tanika T. Williamson
Nadine Nelson
Tomar Ghansah
author_facet Kazim Husain
Tanika T. Williamson
Nadine Nelson
Tomar Ghansah
author_sort Kazim Husain
collection DOAJ
description Protein kinase CK2, formally known as casein kinase II, is ubiquitously expressed and highly conserved serine/threonine or tyrosine kinase enzyme that regulates diverse signaling pathways responsible for cellular processes (i.e., cell proliferation and apoptosis) via interactions with over 500 known substrates. The enzyme’s physiological interactions and cellular functions have been widely studied, most notably in the blood and solid malignancies. CK2 has intrinsic role in carcinogenesis as overexpression of CK2 subunits (α, α`, and β) and deregulation of its activity have been linked to various forms of cancers. CK2 also has extrinsic role in cancer stroma or in the tumor microenvironment (TME) including the immune cells. However, very few research studies have focused on extrinsic role of CK2 in regulating immune responses as a therapeutic alternative for cancer. The following review discusses CK2’s regulation of key signaling events [Nuclear factor kappa B (NF-κB), Janus kinase/signal transducer and activators of transcription (JAK/STAT), Hypoxia inducible factor–1alpha (HIF-1α), Cyclooygenase-2 (COX-2), Extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK), Notch, Protein kinase B/AKT, Ikaros and Wnt] that can influence the development and function of immune cells in cancer. Potential clinical trials using potent CK2 inhibitors will facilitate and improve the treatment of human malignancies.
first_indexed 2024-12-14T09:25:48Z
format Article
id doaj.art-d56efb2c111040db87257138964c3062
institution Directory Open Access Journal
issn 2578-5826
language English
last_indexed 2024-12-14T09:25:48Z
publishDate 2021-07-01
publisher Taylor & Francis Group
record_format Article
series Immunological Medicine
spelling doaj.art-d56efb2c111040db87257138964c30622022-12-21T23:08:11ZengTaylor & Francis GroupImmunological Medicine2578-58262021-07-0144315917410.1080/25785826.2020.18432671843267Protein kinase 2 (CK2): a potential regulator of immune cell development and function in cancerKazim Husain0Tanika T. Williamson1Nadine Nelson2Tomar Ghansah3Department of Molecular Medicine, University of South FloridaDepartment of Molecular Medicine, University of South FloridaDepartment of Molecular Medicine, University of South FloridaDepartment of Molecular Medicine, University of South FloridaProtein kinase CK2, formally known as casein kinase II, is ubiquitously expressed and highly conserved serine/threonine or tyrosine kinase enzyme that regulates diverse signaling pathways responsible for cellular processes (i.e., cell proliferation and apoptosis) via interactions with over 500 known substrates. The enzyme’s physiological interactions and cellular functions have been widely studied, most notably in the blood and solid malignancies. CK2 has intrinsic role in carcinogenesis as overexpression of CK2 subunits (α, α`, and β) and deregulation of its activity have been linked to various forms of cancers. CK2 also has extrinsic role in cancer stroma or in the tumor microenvironment (TME) including the immune cells. However, very few research studies have focused on extrinsic role of CK2 in regulating immune responses as a therapeutic alternative for cancer. The following review discusses CK2’s regulation of key signaling events [Nuclear factor kappa B (NF-κB), Janus kinase/signal transducer and activators of transcription (JAK/STAT), Hypoxia inducible factor–1alpha (HIF-1α), Cyclooygenase-2 (COX-2), Extracellular signal-regulated kinase/mitogen-activated protein kinase (ERK/MAPK), Notch, Protein kinase B/AKT, Ikaros and Wnt] that can influence the development and function of immune cells in cancer. Potential clinical trials using potent CK2 inhibitors will facilitate and improve the treatment of human malignancies.http://dx.doi.org/10.1080/25785826.2020.1843267protein kinase ck2immune cellscancer chemotherapyck2 inhibitors and immunotherapy
spellingShingle Kazim Husain
Tanika T. Williamson
Nadine Nelson
Tomar Ghansah
Protein kinase 2 (CK2): a potential regulator of immune cell development and function in cancer
Immunological Medicine
protein kinase ck2
immune cells
cancer chemotherapy
ck2 inhibitors and immunotherapy
title Protein kinase 2 (CK2): a potential regulator of immune cell development and function in cancer
title_full Protein kinase 2 (CK2): a potential regulator of immune cell development and function in cancer
title_fullStr Protein kinase 2 (CK2): a potential regulator of immune cell development and function in cancer
title_full_unstemmed Protein kinase 2 (CK2): a potential regulator of immune cell development and function in cancer
title_short Protein kinase 2 (CK2): a potential regulator of immune cell development and function in cancer
title_sort protein kinase 2 ck2 a potential regulator of immune cell development and function in cancer
topic protein kinase ck2
immune cells
cancer chemotherapy
ck2 inhibitors and immunotherapy
url http://dx.doi.org/10.1080/25785826.2020.1843267
work_keys_str_mv AT kazimhusain proteinkinase2ck2apotentialregulatorofimmunecelldevelopmentandfunctionincancer
AT tanikatwilliamson proteinkinase2ck2apotentialregulatorofimmunecelldevelopmentandfunctionincancer
AT nadinenelson proteinkinase2ck2apotentialregulatorofimmunecelldevelopmentandfunctionincancer
AT tomarghansah proteinkinase2ck2apotentialregulatorofimmunecelldevelopmentandfunctionincancer